Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials.
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process.
Develop Effective Immunogenicity Risk Mitigation StrategiesImmunogenicity assessment is a prerequisite for the successful development of biopharmaceuticals, including safety and efficacy evaluation.
Revenue cycle management (RCM) refers to an institution's financial management process that helps track, identify, collect, and manage incoming payments.
This monograph on measurement error and misclassification covers a broad range of problems and emphasizes unique features in modeling and analyzing problems arising from medical research and epidemiological studies.
Since the publication of the first edition, Biostatistics and Epidemiology has attracted loyal readers from across specialty areas in the biomedical community.
The Ebola Virus and West Africa: Medical and Sociocultural Aspects provides a compact summary of the Ebola virus, outlining its nature, history, epidemiology, and methods of treatment.
An attractive feature of self-regulation therapies is that, instead of doing something to the patients, they teach them to do something for them- selves.
This volume is a summary of material presented in the course given in the International School of Phannacology on "e;Drug Epidemiology and Post-Marketing Surveillance"e; between September 27 and October 8, 1990, at the "e;Ettore Majorana Center for Scientific Culture"e; in Erice, Sicily.
In this groundbreaking work, distinguished contributors explore the myriad relationships between networks of social support and the development, treatment, and rehabilitation of individuals with cardiovascular disease.
The 1989 Annual Meeting of the Society for Risk Analysis dramatically demonstrated one of the most important reasons for having the Society - to bring together people with highly diverse backgrounds and disciplines to assess the common problems of societal and individual risks.
From the President of the Research Society on Alcoholism In recent years the alcohol research field has matured and is attracting a substantial number of eager and technically sophisticated researchers.
From the President of the Research Society on Alcoholism In recent years, increasingly convincing evidence in support of a biobehavioral conceptual model of the etiology of alcoholism has emerged.
From the President of the Research Society on Alcoholism In the last decade research concerning the causes and consequences of alcohol abuse and alcoholism has come of age.
Here is the first comprehensive cross-disciplinary work to examine the current health situation of our immigrants, successfully integrating the vast literature of diverse fields -- epidemiology, health services research, anthropology, law, medicine, social work, health promotion, and bioethics -- to explore the richness and diversity of the immigrant population from a culturally-sensitive perspective.
From the President of the American Society of Addiction Medicine Recent Developments in Alcoholism (Volume 10) is a major contribution to the literature of addiction medicine.
The incidence of insulin-dependent diabetes mellitus (100M) varies dramatically across racial groups and countries, with annual age-adjusted rates of approximately 40/100,000 per year in Finland, but only 0.
This book is a summary of the presentations and discussions at the Workshop on Methods of Pesticide Exposure Assessment held in Ottawa, Canada, on October 5-8, 1993.
Distinguished contributors analyze the problem of homelessness from a clinical perspective, focusing on the major health problems found among the homeless, special populations within the homeless, and strategies for improvement and change.
The disability-adjusted life year (DALY) is a generic measure of health effect that can be used in cost-effectiveness analysis as an alternative to the quality-adjusted life year (QALY).